Takeda Pharmaceutical Co Ltd (TAK)
13.26
+0.07
(+0.53%)
USD |
NYSE |
May 02, 12:35
Takeda Pharmaceutical Shares Outstanding: 3.138B for Feb. 2, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 02, 2024 | 3.138B |
December 31, 2023 | 3.138B |
October 30, 2023 | 3.138B |
September 30, 2023 | 3.138B |
August 01, 2023 | 3.109B |
June 30, 2023 | 3.109B |
March 31, 2023 | 3.109B |
February 07, 2023 | 3.121B |
December 31, 2022 | 3.109B |
November 04, 2022 | 3.109B |
September 30, 2022 | 3.109B |
June 30, 2022 | 3.092B |
April 30, 2022 | 3.105B |
March 31, 2022 | 3.119B |
February 28, 2022 | 3.101B |
February 10, 2022 | 3.133B |
January 31, 2022 | 3.133B |
December 31, 2021 | 3.115B |
November 30, 2021 | 3.115B |
November 05, 2021 | 3.146B |
October 31, 2021 | 3.146B |
September 30, 2021 | 3.146B |
August 06, 2021 | 3.145B |
June 30, 2021 | 3.137B |
May 11, 2021 | 3.153B |
Date | Value |
---|---|
March 31, 2021 | 3.127B |
February 12, 2021 | 3.153B |
December 31, 2020 | 3.127B |
November 10, 2020 | 3.127B |
September 30, 2020 | 3.127B |
August 12, 2020 | 3.126B |
June 30, 2020 | 3.126B |
March 31, 2020 | 3.116B |
February 13, 2020 | 3.115B |
December 31, 2019 | 3.115B |
November 12, 2019 | 3.153B |
September 30, 2019 | 3.115B |
August 09, 2019 | 3.153B |
June 27, 2019 | 3.110B |
March 31, 2019 | 3.110B |
February 14, 2019 | 3.103B |
January 08, 2019 | 3.103B |
December 31, 2018 | 1.563B |
November 08, 2018 | 1.563B |
October 19, 2018 | 1.563B |
September 30, 2018 | 1.563B |
August 10, 2018 | 1.563B |
June 30, 2018 | 1.563B |
June 28, 2018 | 1.563B |
March 31, 2018 | 1.563B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
3.092B
Minimum
Jun 30 2022
3.153B
Maximum
Feb 12 2021
3.126B
Average
3.126B
Median
Jun 30 2020
Shares Outstanding Benchmarks
Hoya Corp | 350.52M |
Astellas Pharma Inc | 1.793B |
Nxera Pharma Co Ltd | 89.45M |
PeptiDream Inc | 129.61M |
Stemcell Holdings Inc | 27.38M |